LoQus23 Therapeutics adds Florian Muellershausen to its Board along with raising £7m seed financing led by NVF
– UK, Cambridge – LoQus23 Therapeutics Ltd. today announced the closing of its £7 million extended seed round secured from Novartis Venture Fund and founding investor the Dementia Discovery Fund.…